Back to search

Switzerland· 00534003

Engerix-B 20, Injektionssuspension

A hepatitis b, gereinigtes antigen product containing hepatitidis b viri antigenum adnr, registered in Switzerland by GlaxoSmithKline AG and dispensed under Swissmedic category B. The same ATC class is registered in 11 of our 19 countries.

Cat B (Swissmedic)ATC J07BC01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedEngerix-B 20, InjektionssuspensionATCJ07BC01REGISTER NO.00534003PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Hepatitis b, gereinigtes antigen is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BC01 (hepatitis b, gereinigtes antigen), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Hepatitis b, gereinigtes antigen · ATC J07BC01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
hepatitidis B viri antigenum ADNr
Manufacturer
GlaxoSmithKline AG
Country
Switzerland (CH)
ATC code
J07BC01
ATC class
Hepatitis B, gereinigtes Antigen
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

255 interactions on record for hepatitis b, gereinigtes antigen.

Graded by severity as the source publishes them — 255 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Hepatitis b, gereinigtes antigen · interactions on record

255 records

  • 255 moderate

Most severe, free to view

  • PrednisoloneA07EA01moderate
  • HydrocortisoneA07EA02moderate
  • PrednisoneA07EA03moderate
  • BetamethasoneA07EA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2edcf2d-8c48-41df-aa0e-8f467bf27a7a
GET /v1/drugs/f2edcf2d-8c48-41df-aa0e-8f467bf27a7a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

See everything about hepatitis b, gereinigtes antigen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.